Chief Economist

Diana Choyleva

Enodo Economics

Enodo Economics is an independent macroeconomic forecasting company that untangles complexity, challenges the consensus, and makes sense of the future. Our focus is on China – one of the most misunderstood economies in the world, but one of the most important to figure out.  Enodo’s chief economist, Diana Choyleva, has been analysing China for almost 20 years, while Enodo’s team boasts a combined 140 years’ experience covering China’s economy, politics and markets. 

Macroeconomics

<h2>China News That Matters</h2><ul>
<li>A splintering sound, heard around the world</li>
<li>Dual circulation prescribed for China’s economy</li>
<li>More support for semiconductors </li>
<li>Spend your cash while you can</li>
<li>It won’t hurt, much</li>
</ul><div class="content-remarks"><p>In my weekly digest China News That Matters, I will give you selected summaries, sourced from a variety of local Chinese-language and international news outlets, and highlight why I think the news is significant. These posts are meant to neither be bullish nor bearish, but help you separate the signal from the noise.</p></div>

China News That Matters
A splintering sound, heard around the world
Dual circulation prescribed for China’s economy
More support for semiconductors 
Spend your cash while you can
It won’t hurt, much
In my weekly digest China News That Matters, I will give you selected summaries, sourced from a variety of local Chinese-language and international news outlets, and highlight why I think the news is significant. These posts are meant to neither be bullish nor bearish, but help you separate the signal from the noise.

US-China/Economy/Chips/Digital Currency/Vaccines

HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Equity Capital Markets

Wuhan Ammunition Life-Tech / Equity Capital Markets

<ul>
<li>The products of Ammunition play more of an auxiliary and supplementary role compared to the gold standards that have been widely recognized and used in the industry for many years.</li>
<li>The concern is the clinical application may be limited due to doctors' lack of sufficient trust/recognition on such products.So, Ammunition needs to invest heavily in doctor education and market promotion.</li>
<li>The market may give more conservative valuations to enterprises that are still in the stage of "burning money" to gain market share. Valuation of Ammunition could be lower than peer</li>
</ul>


The products of Ammunition play more of an auxiliary and supplementary role compared to the gold standards that have been widely recognized and used in the industry for many years.
The concern is the clinical application may be limited due to doctors' lack of sufficient trust/recognition on such products.So, Ammunition needs to invest heavily in doctor education and market promotion.
The market may give more conservative valuations to enterprises that are still in the stage of "burning money" to gain market share. Valuation of Ammunition could be lower than peer


Pre-IPO Wuhan Ammunition Life-Tech - About The Products and the Concerns Behind

Thematic Investing in Tech and Media, CM Research

Cyrus Mewawalla

Thematic Investing in Tech and Media

Thematic TMT investing

CM Research

CM Research is an independent research house based in London, England. We provide global thematic research in the Technology, Media and Telecoms (TMT) sectors. 

Our focus is on disruptive technologies: how will they unfold; which industries will be impacted; and who will be the ultimate winners and losers. 

Our aim is to help investors predict share prices and corporate executives stay one step ahead of the technology trends that are shaping their industry. 

We research technology investment themes in detail and then feed the results into a scorecard system to quantify the impact of several conflicting themes on individual stocks. 

Recent themes covered include internet TV, the Internet of Things, Big Data, Mobile payments, crowdfunding, artificial intelligence, the cloud, software defined networking and Generation Hashtag.

We cover the top 500 global TMT stocks by market capitalisation and several technology start-ups and pre-IPO companies too. 

In 2015, CM Research analysts outperformed the Bloomberg Benchmark Analyst Index - which measures how good analysts are at predicting stock prices - by 7.1%.

Thematic (Sector/Industry)

<p>Genomics as an investment theme</p><ul><li>Costs of sequencing a human genome have fallen to less than $1,000</li><li>China leads the world in gene sequencing</li><li>The private sector is where the most interesting MedTech companies can be found</li></ul>

Genomics as an investment themeCosts of sequencing a human genome have fallen to less than $1,000China leads the world in gene sequencingThe private sector is where the most interesting MedTech companies can be found

Index Rebal/Special Situations, Quiddity Advisors

Janaghan Jeyakumar, CFA

Index Rebal/Special Situations

Quiddity Advisors

Pan-Asia Catalysts/Events

Index Rebalance

<ul>
<li>The ChiNext index represents the performance of the 100 largest and most liquid A-share stocks listed on the ChiNext Market of the Shenzhen Stock Exchange.</li>
<li>The ChiNext 50 index is a subset of the ChiNext Index and it consists of the top 50 names in the ChiNext index with the highest daily average turnover.</li>
<li>We see 8 changes for the ChiNext index and 5 changes for the ChiNext 50 index in the next index rebal event in June 2026.</li>
</ul>


The ChiNext index represents the performance of the 100 largest and most liquid A-share stocks listed on the ChiNext Market of the Shenzhen Stock Exchange.
The ChiNext 50 index is a subset of the ChiNext Index and it consists of the top 50 names in the ChiNext index with the highest daily average turnover.
We see 8 changes for the ChiNext index and 5 changes for the ChiNext 50 index in the next index rebal event in June 2026.


Quiddity Leaderboard ChiNext & ChiNext 50 Jun26: Expected ADDs/DELs Can Change; US$1bn+ One-Way

<ul>
<li>The ChiNext index represents the performance of the 100 largest and most liquid A-share stocks listed on the ChiNext Market of the Shenzhen Stock Exchange.</li>
<li>The ChiNext 50 index is a subset of the ChiNext Index and it consists of the top 50 names in the ChiNext index with the highest daily average turnover.</li>
<li>We see 7 changes for the ChiNext index and 5 changes for the ChiNext 50 index in the next index rebal event in June 2026.</li>
</ul>


The ChiNext index represents the performance of the 100 largest and most liquid A-share stocks listed on the ChiNext Market of the Shenzhen Stock Exchange.
The ChiNext 50 index is a subset of the ChiNext Index and it consists of the top 50 names in the ChiNext index with the highest daily average turnover.
We see 7 changes for the ChiNext index and 5 changes for the ChiNext 50 index in the next index rebal event in June 2026.


Quiddity Leaderboard ChiNext & ChiNext 50 Jun26: Some Changes to Expectations

China

BGI Genomics Co., Ltd offers researching and testing services. The Company provides deoxyribonucleic acid sequencing, food science, health care researching, cancer prevention, drug discovery, and DNA sequencing. BGI Genomics offers services to medical and scientific research institutions worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

BGI Genomics (300676 CH)

US-China/Economy/Chips/Digital Currency/Vaccines

China News That Matters A splintering sound, heard around the world Dual circulation prescribed for China’s economy More support for...

Diana Choyleva

Pre-IPO Wuhan Ammunition Life-Tech - About The Products and the Concerns Behind

Compared to gold standards, Ammunition's products face challenges in gaining trust from doctors/market recognition, requiring heavy investment in...

Xinyao (Criss) Wang

Genomics as an Investment Theme

Genomics as an investment theme Costs of sequencing a human genome have fallen to less than $1,000 China leads the world in gene sequencing The...

CM Research

Quiddity Leaderboard ChiNext & ChiNext 50 Jun26: Expected ADDs/DELs Can Change; US$1bn+ One-Way

We expect there to be US$899mn and US$216mn one-way flows for the ChiNext and ChiNext 50 in June 2026. Some names have double impacts.

Janaghan Jeyakumar, CFA

Quiddity Leaderboard ChiNext & ChiNext 50 Jun26: Some Changes to Expectations

We see one-way flows of US$1.2bn and US$341mn for the ChiNext index and ChiNext 50 index respectively. Some names have multiple days of volume to...

Janaghan Jeyakumar, CFA

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

US-China/Economy/Chips/Digital Currency/Vaccines

China News That Matters A splintering sound, heard around the world Dual circulation prescribed for China’s economy More support for...

Diana Choyleva

Pre-IPO Wuhan Ammunition Life-Tech - About The Products and the Concerns Behind

​Compared to gold standards, Ammunition's products face challenges in gaining trust from doctors/market recognition, requiring heavy investment in...

Xinyao (Criss) Wang

Genomics as an Investment Theme

Genomics as an investment theme Costs of sequencing a human genome have fallen to less than $1,000 China leads the world in gene sequencing The...

CM Research

Quiddity Leaderboard ChiNext & ChiNext 50 Jun26: Expected ADDs/DELs Can Change; US$1bn+ One-Way

We expect there to be US$899mn and US$216mn one-way flows for the ChiNext and ChiNext 50 in June 2026. Some names have double impacts.

Janaghan Jeyakumar, CFA

Quiddity Leaderboard ChiNext & ChiNext 50 Jun26: Some Changes to Expectations

We see one-way flows of US$1.2bn and US$341mn for the ChiNext index and ChiNext 50 index respectively. Some names have multiple days of volume to...

Janaghan Jeyakumar, CFA

Compared to gold standards, Ammunition's products face challenges in gaining trust from doctors/market recognition, requiring heavy investment in...